Audio Version: Refining PSMA Testing in Prostate Cancer: Next-Generation Imaging Strategies
PSMA imaging has become a key part of prostate cancer for diagnosis, disease staging, and assessing response to therapy. In recent years, several novel PSMA-targeted radiotracers have been developed for PSMA imaging. These are more sensitive, specific, and accurate than other imaging modalities.
Join experts Jason Hafron, MD and David M. Schuster, MD FACR who discuss best practices for the use of PSMA PET/CT in prostate cancer, including the role of PSMA as a biomarker for prostate cancer, data on currently available and emerging PSMA radiotracers, and how best to integrate PSMA PET/CT as an imaging modality in your clinical practice.